FTC Wades Into ‘Rebate Walls’ And Biosimilar Access With Remicade Investigation
Investigation may help define when rebate arrangements seeking to protect a brand against biosimilar competition are anticompetitive.
Investigation may help define when rebate arrangements seeking to protect a brand against biosimilar competition are anticompetitive.